Citation Impact
Citing Papers
First-in-Human Experience of an Antidote-Controlled Anticoagulant Using RNA Aptamer Technology
2006
Administration in non-human primates of escalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunit M2 siRNA
2007
Biomarkers for bile acid diarrhoea in functional bowel disorder with diarrhoea: a systematic review and meta-analysis
2015
Validation of the Rome III Criteria for the Diagnosis of Irritable Bowel Syndrome in Secondary Care
2013
The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research
2009 Standout
Screening Libraries to Discover Molecular Design Principles for the Targeted Delivery of mRNA with One-Component Ionizable Amphiphilic Janus Dendrimers Derived from Plant Phenolic Acids
2023 StandoutNobel
Pharmacokinetic Properties of 2′-O-(2-Methoxyethyl)-Modified Oligonucleotide Analogs in Rats
2001
Celiac disease in T1DM—the need to look long term
2011
Preclinical and Clinical Advances of GalNAc-Decorated Nucleic Acid Therapeutics
2016
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns
2010 Standout
Emerging concepts: from coeliac disease to non-coeliac gluten sensitivity
2012
A randomised pilot trial of the anti-von Willebrand factor aptamer ARC1779 in patients with type 2b von Willebrand disease
2010
The FGF family: biology, pathophysiology and therapy
2009 Standout
Bowel Disorders
2016 Standout
A review of issues in the pharmacokinetics and toxicology of phosphorothioate antisense oligonucleotides
1999
Pancreatic cancer
2020 Standout
Celiac disease in the elderly
2008
Selective spider toxins reveal a role for the Nav1.1 channel in mechanical pain
2016 StandoutNatureNobel
The emerging role of lncRNAs in cancer
2015 Standout
Programmable RNA Tracking in Live Cells with CRISPR/Cas9
2016 StandoutNobel
Nanoparticle therapeutics: an emerging treatment modality for cancer
2008 Standout
A matter of life and death
2002 Standout
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Nutrition Assessment in Celiac Disease
2012
Delivery materials for siRNA therapeutics
2013 Standout
Use of minimally modified antisense oligonucleotides for specific inhibition of gene expression
2000
Epidemiology and risk factors for IBD
2015 Standout
Therapeutic targeting of microRNAs: current status and future challenges
2014
The Irritable Bowel Syndrome-Celiac Disease Connection
2012
ACG Clinical Guidelines: Diagnosis and Management of Celiac Disease
2013 Standout
LYTACs that engage the asialoglycoprotein receptor for targeted protein degradation
2021 StandoutNobel
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
2010 StandoutNature
Irritable bowel syndrome
2016 Standout
Celiac disease: Prevalence, diagnosis, pathogenesis and treatment
2012
Increased prevalence of chronic kidney disease in patients with Type 1 diabetes and non‐alcoholic fatty liver
2011
Aptamers as therapeutics
2010 Standout
Non-viral vectors for gene-based therapy
2014 Standout
Screening for Celiac Disease in Irritable Bowel Syndrome: An Updated Systematic Review and Meta-analysis
2016
The Prevalence of Celiac Disease in Children and Adolescents in Germany
2015
Risk of Pancreatitis in 14,000 Individuals With Celiac Disease
2007
The Epidemiology of Pancreatitis and Pancreatic Cancer
2013 Standout
Aptamers as targeted therapeutics: current potential and challenges
2016 Standout
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
2018 Standout
Water-soluble carbosilane dendrimers protect phosphorothioate oligonucleotides from binding to serum proteins
2007
DNA methylation landscapes: provocative insights from epigenomics
2008 Standout
An Association Between Microscopic Colitis and Celiac Disease
2009
Enterochromaffin Cells Are Gut Chemosensors that Couple to Sensory Neural Pathways
2017 StandoutNobel
The phospholipase A2 superfamily and its group numbering system
2006 Standout
Prevalence of a Gluten-free Diet and Improvement of Clinical Symptoms in Patients with Inflammatory Bowel Diseases
2014
Therapeutic RNA aptamers in clinical trials
2012
Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes
2010
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer
2007 Standout
Neuroplasticity and dysfunction after gastrointestinal inflammation
2014
Advances in understanding of bile acid diarrhea
2013
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
2017 Standout
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
2010 Standout
Gastrointestinal symptoms and quality of life in screen-detected celiac disease
2012
Dietary Lipids and Functional Gastrointestinal Disorders
2013
Innate immunity of the newborn: basic mechanisms and clinical correlates
2007 Standout
Revealing the world of RNA interference
2004 StandoutNatureNobel
Effect of Increased Bile Acid Synthesis or Fecal Excretion in Irritable Bowel Syndrome-Diarrhea
2014
Serotonin, tryptophan metabolism and the brain-gut-microbiome axis
2014 Standout
Antisense, RNAi, and gene silencing strategies for therapy: Mission possible or impossible?
2008
The association of coeliac disease and microscopic colitis: a large population-based study
2011
Double blind, placebo controlled trial of the remission inducing and steroid sparing properties of an ICAM-1 antisense oligodeoxynucleotide, alicaforsen (ISIS 2302), in active steroid dependent Crohn's disease
2002
Real time endoscopic ultrasound elastography and strain ratio in the diagnosis of solid pancreatic lesions
2017
Review: Management of Postprandial Diarrhea Syndrome
2012
Liposomal drug delivery systems: From concept to clinical applications
2012 Standout
Knocking down barriers: advances in siRNA delivery
2009 Standout
Ionization and structural properties of mRNA lipid nanoparticles influence expression in intramuscular and intravascular administration
2021 StandoutNobel
Complement activation is responsible for acute toxicities in rhesus monkeys treated with a phosphorothioate oligodeoxynucleotide
2002
Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable aminolipids: formation of novel small multilamellar vesicle structures
2001
Materials fabrication from Bombyx mori silk fibroin
2011 Standout
A gluten-free diet effectively reduces symptoms and health care consumption in a Swedish celiac disease population
2012
Prevalence of Symptoms Meeting Criteria for Irritable Bowel Syndrome in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
2012
NAFLD: A multisystem disease
2015 Standout
Global Prevalence of Celiac Disease: Systematic Review and Meta-analysis
2018 Standout
Therapeutic potential of Toll-like receptor 9 activation
2006
Prevalence of Irritable Bowel Syndrome–type Symptoms in Patients With Celiac Disease: A Meta-analysis
2012
A novel antisense inhibitor of MMP-9 attenuates angiogenesis, human prostate cancer cell invasion and tumorigenicity
2003
Antisense therapeutics: lessons from early clinical trials
2001
Matrix metalloproteinases and tumor metastasis
2006 Standout
Pharmacokinetics, toxicity, and efficacy of ends-modified raf antisense oligodeoxyribonucleotide encapsulated in a novel cationic liposome.
2002
Ionic-Liquid-Mediated Extraction and Separation Processes for Bioactive Compounds: Past, Present, and Future Trends
2017 Standout
Irritable Bowel Syndrome
2015 Standout
Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation
2009 Standout
A Population-Based Study of the Risk of Diabetic Retinopathy in Patients With Type 1 Diabetes and Celiac Disease
2012
Phosphorothioate Oligonucleotides Inhibit the Intrinsic Tenase Complex
1998
RNA Targeting Therapeutics: Molecular Mechanisms of Antisense Oligonucleotides as a Therapeutic Platform
2010
Patients With Celiac Disease Have an Increased Risk for Pancreatitis
2012
Nonviral Vectors for Gene Delivery
2008 Standout
Progress in the Delivery of Therapeutic Oligonucleotides: Organ/Cellular Distribution and Targeted Delivery of OligonucleotidesIn Vivo
2003
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Nucleic Acid Biotechnology
1999
CpG Motifs in Bacterial DNA and Their Immune Effects
2002 Standout
Phase 1b Randomized Study of Antidote-Controlled Modulation of Factor IXa Activity in Patients With Stable Coronary Artery Disease
2008
Gut hormones: emerging role in immune activation and inflammation
2010
Phase I Safety and Pharmacokinetic Profile of an Intercellular Adhesion Molecule-1 Antisense Oligodeoxynucleotide (ISIS 2302)
1997
Preclinical Evaluation of the Toxicological Effects of a Novel Constrained Ethyl Modified Antisense Compound Targeting Signal Transducer and Activator of Transcription 3 in Mice and Cynomolgus Monkeys
2013
Iron-Deficiency Anemia
2015 Standout
First-in-Human Evaluation of Anti–von Willebrand Factor Therapeutic Aptamer ARC1779 in Healthy Volunteers
2007
Overlapping irritable bowel syndrome and inflammatory bowel disease: less to this than meets the eye?
2015
Systematic review with meta‐analysis: the prevalence of bile acid malabsorption in the irritable bowel syndrome with diarrhoea
2015
Review article: gut‐directed hypnotherapy in the management of irritable bowel syndrome and inflammatory bowel disease
2015
Oligodeoxynucleotide Studies in Primates: Antisense and Immune Stimulatory Indications
2003
The use of sulfonated silk fibroin derivatives to control binding, delivery and potency of FGF-2 in tissue regeneration
2009
Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features, and Rome IV
2016 Standout
Works of John Leeds being referenced
Case-finding for coeliac disease in secondary care: A prospective multicentre UK study
2013
Activation of the Alternative Pathway of Complement by a Phosphorothioate Oligonucleotide: Potential Mechanism of Action
1997
Abnormal liver function tests in patients with Type 1 diabetes mellitus: prevalence, clinical correlations and underlying pathologies
2009
Is there an association between coeliac disease and inflammatory bowel diseases? A study of relative prevalence in comparison with population controls
2007
The occurrence of terminal ileal histological abnormalities in patients with coeliac disease
2006
Bile acid malabsorption: An under-investigated differential diagnosis in patients presenting with diarrhea predominant irritable bowel syndrome type symptoms
2011
Is exocrine pancreatic insufficiency in adult coeliac disease a cause of persisting symptoms?
2007
Diagnostic accuracy of quantitative EUS elastography for discriminating malignant from benign solid pancreatic masses: a prospective, single-center study
2012
Inhibition of Coagulation by a Phosphorothioate Oligonucleotide
1997
Coeliac disease
2008
Pancreatic Insufficiency in Adult Celiac Disease: Do Patients Require Long-Term Enzyme Supplementation?
2010
Some Patients With Irritable Bowel Syndrome May Have Exocrine Pancreatic Insufficiency
2009
Prodromal Irritable Bowel Syndrome May Be Responsible for Delays in Diagnosis in Patients Presenting with Unrecognized Crohn’s Disease and Celiac Disease, but Not Ulcerative Colitis
2011
Are lower gastrointestinal investigations necessary in patients with coeliac disease?
2005
Association of Adult Celiac Disease With Surgical Abdominal Pain
2005
Reflux and irritable bowel syndrome are negative predictors of quality of life in coeliac disease and inflammatory bowel disease
2010
The role of serum chromogranin A in diarrhoea predominant irritable bowel syndrome.
2009
High Prevalence of Microvascular Complications in Adults With Type 1 Diabetes and Newly Diagnosed Celiac Disease
2011